Get the Stockscreener App
1.38
0.72%
-0.01
Pre-market:
1.38
Ovid Therapeutics Inc Stock (OVID) Forecast
The Ovid Therapeutics Inc (OVID) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $7.295, representing a +428.62% increase from the current price of $1.38. The highest analyst price target is $7.9153, and the lowest is $6.6747.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month OVID Price Target
Average 6.2984
(+356.41% Upside)
Is Ovid Therapeutics Inc (OVID) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 44.45 | Neutral |
| STOCH(9,6) | 14.50 | Buy |
| STOCHRSI(14) | 4.5202 | Buy |
| MACD(12,26) | -0.00192 | Sell |
| ADX(14) | 29.79 | Buy |
| William %R | -90.48 | Buy |
| CCI(14) | -120.95 | Sell |
Buy: 4
Sell: 2
Neutral: 1
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.508
Sell
|
1.4781
Sell
|
| MA20 |
1.571
Sell
|
1.5062
Sell
|
| MA50 |
1.4266
Sell
|
1.3654
Buy
|
| MA100 |
0.9718
Buy
|
1.1179
Buy
|
| MA200 |
0.7024
Buy
|
0.9539
Buy
|
Buy: 5
Sell: 5
Neutral: 0
Summary: Neutral
According to our latest analysis, OVID could be considered a Strong Buy, with 17 technical analysis indicators signaling 9 Buy signals, 7 signaling Sell signals and 1 Neutral signals. This might be a good time to open fresh positions on OVID, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 44.45 indicates that OVID is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 14.5 indicates that OVID is oversold. This indicates that OVID price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 4.5202 indicates that OVID is oversold. This suggests that OVID price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 29.79 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -120.95 indicates that OVID is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term OVID price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Ovid Therapeutics Inc financial reports and earnings history, Ovid Therapeutics Inc (OVID) stock could reach $4.5073 by 2030, $10.19 by 2040 and $13.24 by 2050. See the projected annual prices until 2050 of the Ovid Therapeutics Inc stock below:
- Ovid Therapeutics Inc (OVID) is expected to reach an average price of $7.9329 in 2035, with a high prediction of $8.2663 and a low estimate of $7.6885. This indicates an $474.85% rise from the last recorded price of $1.38.
- Ovid Therapeutics Inc (OVID) stock is projected to chart a bullish course in 2040, with an average price target of $10.12, representing an $633.18% surge from its current level. The forecast ranges from a conservative $8.9555 to a sky-high $10.19.
- Our analysts predict Ovid Therapeutics Inc (OVID) to jump 623.40% by 2045, soaring from $9.9829 to an average price of $9.9829, potentially reaching $10.39. While $9.9829 is the low estimate, the potential upside is significant.
- Ovid Therapeutics Inc (OVID) stock is expected to climb by 2050, reaching an average of $12.92, a $836.28% jump from its current level. However, a wide range of estimates exists, with high and low targets of $13.24 and $12.78, respectively, highlighting the market's uncertainty.
Ovid Therapeutics Inc Stock (OVID) Year by Year Forecast
Ovid Therapeutics Inc Stock (OVID) Price Forecast for 2025
Ovid Therapeutics Inc Stock (OVID) is expected to reach an average price of $7.1437 in 2025, with a high prediction of $10.97 and a low estimate of $3.3218. This indicates an +417.66% rise from the last recorded price of $1.38.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2025 | $6.7547 | $6.6747 | $7.9153 | +389.47% |
Ovid Therapeutics Inc Stock (OVID) Price Forecast for 2026
The predicted value for Ovid Therapeutics Inc (OVID) in 2026 is set at an average of $6.2984. Estimates vary from a peak of $8.6563 to a trough of $3.9406, indicating an +356.41% surge from the present price of $1.38.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $7.9591 | $6.4783 | $8.0926 | +476.74% |
| February, 2026 | $4.3584 | $4.1399 | $8.6563 | +215.83% |
| March, 2026 | $4.1678 | $3.9406 | $4.407 | +202.02% |
| April, 2026 | $5.1858 | $4.1244 | $5.6858 | +275.78% |
| May, 2026 | $6.2002 | $4.2994 | $6.473 | +349.29% |
| June, 2026 | $5.4345 | $5.4245 | $6.1837 | +293.81% |
| July, 2026 | $5.3425 | $4.9745 | $5.7253 | +287.14% |
| August, 2026 | $6.2669 | $5.2361 | $6.5733 | +354.12% |
| September, 2026 | $5.7348 | $5.5248 | $6.4205 | +315.57% |
| October, 2026 | $5.5192 | $5.382 | $5.7684 | +299.94% |
| November, 2026 | $5.3536 | $5.055 | $6.0128 | +287.94% |
| December, 2026 | $5.1915 | $5.1215 | $5.4908 | +276.20% |
Ovid Therapeutics Inc Stock (OVID) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Ovid Therapeutics Inc (OVID) is $4.632, with a high forecast of $5.6323 and a low forecast of $3.6317. This indicates an +235.65% increase from the last price of $1.38.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $5.4559 | $5.0572 | $5.6323 | +295.36% |
| February, 2027 | $5.3103 | $5.2003 | $5.6031 | +284.80% |
| March, 2027 | $5.1382 | $4.9082 | $5.4842 | +272.34% |
| April, 2027 | $5.0326 | $5.0026 | $5.419 | +264.68% |
| May, 2027 | $4.707 | $4.5048 | $5.0862 | +241.09% |
| June, 2027 | $5.265 | $4.6706 | $5.475 | +281.52% |
| July, 2027 | $5.0893 | $4.9057 | $5.4886 | +268.79% |
| August, 2027 | $4.8937 | $4.8937 | $5.3065 | +254.62% |
| September, 2027 | $3.7217 | $3.6317 | $5.0709 | +169.69% |
| October, 2027 | $3.846 | $3.6389 | $4.0724 | +178.70% |
| November, 2027 | $4.2004 | $3.7846 | $4.2804 | +204.38% |
| December, 2027 | $4.2784 | $3.9512 | $4.3098 | +210.03% |
Ovid Therapeutics Inc Stock (OVID) Price Forecast for 2028
In 2028, Ovid Therapeutics Inc (OVID) is projected to reach an average price of $4.8377, with a high projection of $6.188 and a low estimate of $3.4873. This indicates an +250.55% rise from the last price of $1.38.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $4.0428 | $3.9278 | $4.312 | +192.95% |
| February, 2028 | $3.8971 | $3.8671 | $4.2513 | +182.40% |
| March, 2028 | $3.7051 | $3.5843 | $3.9807 | +168.48% |
| April, 2028 | $3.8895 | $3.4873 | $3.9295 | +181.84% |
| May, 2028 | $3.8074 | $3.7238 | $3.9838 | +175.90% |
| June, 2028 | $4.4218 | $3.7911 | $4.5482 | +220.42% |
| July, 2028 | $4.6162 | $4.3754 | $4.689 | +234.51% |
| August, 2028 | $4.1541 | $4.0541 | $4.7198 | +201.02% |
| September, 2028 | $4.6985 | $4.0577 | $5.0449 | +240.47% |
| October, 2028 | $5.8129 | $4.6221 | $5.8829 | +321.22% |
| November, 2028 | $5.8658 | $5.3965 | $6.0008 | +325.06% |
| December, 2028 | $5.4952 | $5.377 | $6.188 | +298.20% |
Ovid Therapeutics Inc Stock (OVID) Price Forecast for 2029
The 2029 price forecast for Ovid Therapeutics Inc Stock (OVID) is $5.3916 on average, with a high prediction of $6.4518 and a low estimate of $4.3314. This represents an +290.69% increase from the previous price of $1.38.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $5.8232 | $5.4788 | $5.8596 | +321.97% |
| February, 2029 | $6.2026 | $5.3354 | $6.3865 | +349.46% |
| March, 2029 | $6.2319 | $5.5911 | $6.3011 | +351.59% |
| April, 2029 | $5.9463 | $5.6655 | $6.2655 | +330.89% |
| May, 2029 | $5.5443 | $5.3943 | $6.0999 | +301.76% |
| June, 2029 | $5.5036 | $4.875 | $5.8479 | +298.81% |
| July, 2029 | $5.543 | $5.2122 | $6.2194 | +301.67% |
| August, 2029 | $6.211 | $5.3566 | $6.431 | +350.07% |
| September, 2029 | $6.0553 | $5.8582 | $6.4518 | +338.79% |
| October, 2029 | $5.5733 | $4.9733 | $6.1501 | +303.86% |
| November, 2029 | $5.6177 | $5.3769 | $5.7305 | +307.08% |
| December, 2029 | $4.4057 | $4.3314 | $5.8449 | +219.25% |
Ovid Therapeutics Inc Stock (OVID) Price Forecast for 2030
Ovid Therapeutics Inc Stock (OVID) is expected to reach an average price of $6.2156 in 2030, with a high forecast of $8.1811 and a low forecast of $4.2501. This signifies an +350.41% surge from the last price of $1.38.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $4.4973 | $4.2501 | $4.5073 | +225.89% |
| February, 2030 | $5.3211 | $4.4045 | $5.6961 | +285.59% |
| March, 2030 | $4.8047 | $4.7848 | $5.4033 | +248.17% |
| April, 2030 | $4.5986 | $4.552 | $5.0364 | +233.23% |
| May, 2030 | $6.0895 | $4.5707 | $6.8123 | +341.27% |
| June, 2030 | $5.0182 | $4.9482 | $6.2085 | +263.64% |
| July, 2030 | $5.7342 | $4.9854 | $5.9042 | +315.52% |
| August, 2030 | $7.4329 | $5.7214 | $7.5929 | +438.62% |
| September, 2030 | $6.9067 | $6.6517 | $8.1811 | +400.48% |
| October, 2030 | $6.8326 | $6.2732 | $7.4776 | +395.12% |
| November, 2030 | $5.2663 | $4.9863 | $7.1548 | +281.62% |
| December, 2030 | $5.7801 | $4.8435 | $6.1479 | +318.85% |
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):